Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Gynecol Oncol ; 186: 204-210, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38843663

ABSTRACT

OBJECTIVE: Elevated allostatic load (AL), an integrated, cumulative marker of physiologic damage due to socioenvironmental stress, is associated with increased mortality in patients with breast, lung, and other cancers. The relationship between allostatic load and mortality in ovarian cancer patients remains unknown. We examined the relationship between allostatic load and overall survival in ovarian cancer patients. METHODS: This cross-sectional study used data from 201 patients enrolled in a prospective observational ovarian cancer cohort study at a National Cancer Institute-designated Comprehensive Cancer Center from October 2012 through June 2022. All patients underwent debulking surgery and completed a full course of standard-of-care platinum-based chemotherapy. Follow-up was completed through January 2024. Allostatic load was calculated as a summary score by assigning one point to the worst sample quartile for each of ten biomarkers measured within 45 days before the ovarian cancer diagnosis. High allostatic load was defined as having an allostatic load in the top quartile of the summary score. A Cox proportional hazard model with robust variance tested the association between allostatic load and overall survival. RESULTS: There were no associations between allostatic load and ovarian cancer clinical characteristics. After accounting for demographic, clinical, and treatment factors, high allostatic load was associated with a significant increase in mortality (hazard ratio 2.17 [95%CI, 1.13-4.15]; P = 0.02). CONCLUSION: Higher allostatic load is associated with worse survival among ovarian cancer patients. Allostatic load could help identify patients at risk for poorer outcomes who may benefit from greater socioenvironmental support during treatment.


Subject(s)
Allostasis , Carcinoma, Ovarian Epithelial , Ovarian Neoplasms , Humans , Female , Carcinoma, Ovarian Epithelial/mortality , Carcinoma, Ovarian Epithelial/surgery , Carcinoma, Ovarian Epithelial/pathology , Carcinoma, Ovarian Epithelial/physiopathology , Middle Aged , Allostasis/physiology , Ovarian Neoplasms/mortality , Ovarian Neoplasms/pathology , Aged , Cross-Sectional Studies , Prospective Studies , Adult , Cohort Studies , Proportional Hazards Models
2.
Assist Technol ; 26(4): 219-26, 2014.
Article in English | MEDLINE | ID: mdl-25771607

ABSTRACT

Vision-impaired individuals often use a long white cane to assist them with gathering information about their surroundings. However, these aids are generally not used to detect obstacles above knee height. The purpose of this study is to determine whether a low-cost, custom-built electronic device clipped onto a traditional cane can provide adequate vibratory warning to the user of obstacles above knee height. Sixteen normally sighted blindfolded individuals participated in two mobility courses which they navigated using a normal white cane and a white cane with the electronic device attached. Of the 16 participants, 10 hit fewer obstacles, and 12 covered less ground with the cane when the electronic device was attached. Ten participants found navigating with the electronic device easier than just the white cane alone. However, the time taken on the mobility courses, the number of collisions with obstacles, and the area covered by participants using the electronic device were not significantly different (p > 0.05). A larger sample size is required to determine if the trends found have real significance. It is anticipated that additional information provided by this electronic device about the surroundings would allow users to move more confidently within their environment.


Subject(s)
Canes , Self-Help Devices , Spatial Navigation , Vibration , Visually Impaired Persons , Activities of Daily Living , Electronics , Equipment Design , Humans , Mobility Limitation
3.
Clin Exp Optom ; 95(5): 473-83, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22823954

ABSTRACT

Complete loss of vision is one of the most feared sequelae of retinal disease. Currently, there are few if any treatment options available to patients that may slow or prevent blindness in diseases caused by photoreceptor loss, such as retinitis pigmentosa and age-related macular degeneration. Electronic restoration of vision has emerged over recent years as a safe and viable option for those who have lost substantial numbers of photoreceptors and who are severely vision impaired. Indeed, there has been a dramatic increase in our understanding of what is required to restore vision using an electronic retinal prosthesis. Recent reports show that for some patients, restoration of vision to the point of reading large letters is possible. In this review, we examine the types of implants currently under investigation and the results these devices have achieved clinically. We then consider a range of engineering and biological factors that may need to be considered to improve the visual performance of newer-generation devices. With added research, it is hoped that the level of vision achieved with newer generation devices will steadily improve, resulting in enhanced quality of life for those with severe vision impairment.


Subject(s)
Electric Stimulation Therapy/methods , Macular Degeneration/surgery , Photoreceptor Cells/cytology , Prosthesis Implantation/methods , Retinitis Pigmentosa/surgery , Vision, Ocular , Humans , Macular Degeneration/physiopathology , Patient Selection , Prosthesis Implantation/instrumentation , Retinitis Pigmentosa/physiopathology
4.
Article in English | MEDLINE | ID: mdl-21096097

ABSTRACT

Retinal prostheses aim to restore vision to patients who are blind from photoreceptor diseases such as Retinitis Pigmentosa (RP). All implants target the neural cells in the inner retina, the retinal ganglion cells (RGCs). Our research focuses on further understanding the disease process of RP during mid to late stages when total loss of photoreceptors has occurred and significant remodeling of inner retinal neurons has taken place. We have used a novel transgenic mouse, Rd1-FTL, to observe different degenerative stages of RP. Notably, in the aged retina we have evidence that there was gross inner retinal remodeling as well as glial dysfunction that occurred in confined regions in the central retina that worsened overtime. Consequently, the timing of implantation and location of the prosthesis both need to account for the state of the retina at different stages in the disease process.


Subject(s)
Disease Models, Animal , Retina/cytology , Retinal Ganglion Cells/metabolism , Retinitis Pigmentosa/pathology , Age Factors , Animals , Cell Movement , Cell Survival/physiology , Immunohistochemistry , Mice , Mice, Transgenic , Proto-Oncogene Proteins c-fos/metabolism , Retina/metabolism , Retinitis Pigmentosa/metabolism , Retinitis Pigmentosa/physiopathology , Visual Prosthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...